Versant Venture Management, LLC — 13F Holdings

2026 Q2  ·  8 Positions

2026 Q2 Portfolio Activity

In 2026 Q2, Versant Venture Management, LLC maintained a portfolio of 8 distinct positions. The fund also reduced its exposure to Jade Biosciences, Inc. by 35.0%.
Position History hover any row below to update
Loading…
Versant Venture Management, LLC San Francisco, CA Venture Capital / Asset Manager AUM $163M
Fund Overview SEC EDGAR
PCA Score Concentration Risk
Risk ENB
To Excel To CSV
Total Positions
8
Quarter
2026 Q2
Top Holding
GLUE (47.3%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-8 of 8
Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
GLUE
Monte Rosa Ther...
Healthcare 47.34% 37.00% #1
Prev: #1
7.0
—
no change no change
P
S
3,180,780 $76,974,876 2024 Q4 13F Filing 2026-06-30 2026-08-12
IPSC
Century Therape...
Healthcare 18.33% 19.44% #2
Prev: #2
6.5
—
no change no change
P
S
12,166,109 $29,806,967 2026 Q1 13F Filing 2026-06-30 2026-08-12
JBIO
Jade Bioscience...
Healthcare 13.55% 15.16% #3 1
Prev: #4
5.0
—
-534,037 -35.0%
P
S
991,783 $22,037,418 2025 Q2 13F Filing 2026-06-30 2026-08-12
LENZ
Lenz Therapeuti...
Healthcare 9.28% 17.19% #4 1
Prev: #3
5.2
—
no change no change
P
S
2,656,888 $15,091,124 2025 Q3 13F Filing 2026-06-30 2026-08-12
CTNM
Contineum Thera...
Healthcare 5.47% 5.01% #5
Prev: #5
3.7
—
no change no change
P
S
542,628 $8,893,673 2024 Q2 13F Filing 2026-06-30 2026-08-12
CRSP
CRISPR Therapeu...
Healthcare 4.99% 5.01% #6
Prev: #6
3.0
—
no change no change
P
S
148,831 $8,117,243 2018 Q1 13F Filing 2026-06-30 2026-08-12
SKYE
Skye Bioscience...
Healthcare 0.86% 0.87% #7
Prev: #7
1.3
—
no change no change
P
S
2,007,704 $1,391,941 2024 Q1 13F Filing 2026-06-30 2026-08-12
N/A
Tempest Therape...
Unknown 0.18% 0.31% #8
Prev: #8
1.1
—
no change no change
P
S
269,772 $299,447 — 13F Filing 2026-06-30 2026-08-12
Showing 1-8 of 8 holdings

Unlock Full Versant Venture Management, LLC Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Upgrade to PRO
Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →